Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)

Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)

Chitosan oligosaccharides (COS) display various biological activities. In this study, we aimed to explore the preventive effects of COS on glucolipid metabolism disorder using palmitic acid (PA)-induced HepG2 cells and high-fat diet (HFD)-fed C57BL/6J mice as experimental models in vitro and in vivo...

Full description

Bibliographic Details
Main Authors: Yibo Bai, Junping Zheng, Xubing Yuan, Siming Jiao, Cui Feng, Yuguang Du, Hongtao Liu, Lanyan Zheng
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Marine Drugs
Subjects:
chitosan oligosaccharide
glucolipid metabolism disorder
high-fat diet
inflammation
peroxisome proliferator-activated receptor gamma
Online Access:https://www.mdpi.com/1660-3397/16/11/455

Similar Items

Similar Items